A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies

The objective of the present study was to evaluate the contribution of the shared epitope (SE), the rheumatoid arthritis (RA) protection model, and the occurrence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in RA patients from a genetically diverse population. One hundred and forty Br...

Full description

Bibliographic Details
Main Authors: P. Louzada-Júnior, M.V.C. Freitas, R.D.R. Oliveira, N.H.S. Deghaide, R.A. Conde, M.B. Bertolo, E.A. Donadi
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2008-06-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000600010
_version_ 1818849313585889280
author P. Louzada-Júnior
M.V.C. Freitas
R.D.R. Oliveira
N.H.S. Deghaide
R.A. Conde
M.B. Bertolo
E.A. Donadi
author_facet P. Louzada-Júnior
M.V.C. Freitas
R.D.R. Oliveira
N.H.S. Deghaide
R.A. Conde
M.B. Bertolo
E.A. Donadi
author_sort P. Louzada-Júnior
collection DOAJ
description The objective of the present study was to evaluate the contribution of the shared epitope (SE), the rheumatoid arthritis (RA) protection model, and the occurrence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in RA patients from a genetically diverse population. One hundred and forty Brazilian RA patients and 161 matched controls were typed for HLA-DRB1 alleles using amplified DNA hybridized with sequence-specific oligonucleotide probes or primers. Patients were stratified according to the presence or absence of SE (DRB1*0401, *0404, *0405, *0101, *1001, and *1402), of the DERAA alleles (DRB1*0103, *0402, *1102, *1103, *1301, *1302, and *1304), and X (all other alleles). Anti-CCP antibodies were measured by ELISA. The combined frequency of SE-positive alleles was significantly greater (76.4 vs 23.6%, P < 0.0001) than the controls. The SE/SE and SE/X genotypes were over-represented (P < 0.0001, OR = 6.02) and DERAA/X was under-represented in RA patients (P < 0.001, OR = 0.49), whereas the frequencies of the SE/DERAA, X/X and X/DERAA genotypes were not significantly different from controls. The frequency of anti-CCP antibodies was higher in SE-positive patients than in SE-negative patients (64.6 vs 44.7%, P = 0.03; OR = 2.25). Although the Brazilian population is highly miscegenated, the results of this study support the findings observed in most genetically homogeneous populations with RA; however, they are not mutually exclusive but rather complementary. The participation of DRB1-DERAA alleles in protection against RA was also observed (OR = 0.4; 95%CI = 0.23-0.68).
first_indexed 2024-12-19T06:31:15Z
format Article
id doaj.art-e3c16dc0e0274ff3ae95ea4cdfd94962
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-12-19T06:31:15Z
publishDate 2008-06-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-e3c16dc0e0274ff3ae95ea4cdfd949622022-12-21T20:32:23ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2008-06-01416493499A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodiesP. Louzada-JúniorM.V.C. FreitasR.D.R. OliveiraN.H.S. DeghaideR.A. CondeM.B. BertoloE.A. DonadiThe objective of the present study was to evaluate the contribution of the shared epitope (SE), the rheumatoid arthritis (RA) protection model, and the occurrence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in RA patients from a genetically diverse population. One hundred and forty Brazilian RA patients and 161 matched controls were typed for HLA-DRB1 alleles using amplified DNA hybridized with sequence-specific oligonucleotide probes or primers. Patients were stratified according to the presence or absence of SE (DRB1*0401, *0404, *0405, *0101, *1001, and *1402), of the DERAA alleles (DRB1*0103, *0402, *1102, *1103, *1301, *1302, and *1304), and X (all other alleles). Anti-CCP antibodies were measured by ELISA. The combined frequency of SE-positive alleles was significantly greater (76.4 vs 23.6%, P < 0.0001) than the controls. The SE/SE and SE/X genotypes were over-represented (P < 0.0001, OR = 6.02) and DERAA/X was under-represented in RA patients (P < 0.001, OR = 0.49), whereas the frequencies of the SE/DERAA, X/X and X/DERAA genotypes were not significantly different from controls. The frequency of anti-CCP antibodies was higher in SE-positive patients than in SE-negative patients (64.6 vs 44.7%, P = 0.03; OR = 2.25). Although the Brazilian population is highly miscegenated, the results of this study support the findings observed in most genetically homogeneous populations with RA; however, they are not mutually exclusive but rather complementary. The participation of DRB1-DERAA alleles in protection against RA was also observed (OR = 0.4; 95%CI = 0.23-0.68).http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000600010Susceptibility to rheumatoid arthritisHLABraziliansShared epitopeAnti-cyclic citrullinated peptide
spellingShingle P. Louzada-Júnior
M.V.C. Freitas
R.D.R. Oliveira
N.H.S. Deghaide
R.A. Conde
M.B. Bertolo
E.A. Donadi
A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies
Brazilian Journal of Medical and Biological Research
Susceptibility to rheumatoid arthritis
HLA
Brazilians
Shared epitope
Anti-cyclic citrullinated peptide
title A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies
title_full A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies
title_fullStr A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies
title_full_unstemmed A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies
title_short A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies
title_sort majority of brazilian patients with rheumatoid arthritis hla drb1 alleles carry both the hla drb1 shared epitope and anti citrunillated peptide antibodies
topic Susceptibility to rheumatoid arthritis
HLA
Brazilians
Shared epitope
Anti-cyclic citrullinated peptide
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000600010
work_keys_str_mv AT plouzadajunior amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT mvcfreitas amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT rdroliveira amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT nhsdeghaide amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT raconde amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT mbbertolo amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT eadonadi amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT plouzadajunior majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT mvcfreitas majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT rdroliveira majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT nhsdeghaide majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT raconde majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT mbbertolo majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies
AT eadonadi majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies